# VOSEVI
> **NDA209195** · New Drug Application · Sponsor: GILEAD SCIENCES INC · Approved 2017-07-18
## Drug
- **FDA Application Number:** NDA209195
- **Application type:** New Drug Application
- **Brand name:** VOSEVI
- **Generic name:** SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR
- **Active ingredients:** SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GILEAD SCIENCES INC
- **Manufacturer:** Gilead Sciences, Inc.
- **First approval:** 2017-07-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209195)
---
*AI Analytics · CC0 1.0*